RECOMBINANT ERYTHROPOIETIN THERAPY IN CANCER-PATIENTS

被引:18
|
作者
BUNN, HF
机构
关键词
D O I
10.1200/JCO.1990.8.6.949
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:949 / 951
页数:3
相关论文
共 50 条
  • [31] Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients
    Beguin, Y
    HAEMATOLOGICA, 2002, 87 (11) : 1209 - 1221
  • [32] Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients
    Fischer, Michael A.
    Morris, Charles A.
    Winkelmayer, Wolfgang C.
    Avorn, Jerry
    ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (08) : 840 - 846
  • [33] THERAPY WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    STONE, RM
    BERNSTEIN, SH
    DEMETRI, G
    FACKLAM, DP
    ARTHUR, K
    ANDERSEN, J
    ASTER, JC
    KUFE, D
    LEUKEMIA RESEARCH, 1994, 18 (10) : 769 - 776
  • [34] RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY OF ANEMIC PATIENTS WITH LUNG TUBERCULOSIS
    Inyakova, N., V
    Demikhov, V. G.
    Dolzhenko, E. N.
    Golovitsyna, O. A.
    Morshchakova, E. F.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (10) : E114 - E114
  • [35] HEMODYNAMIC-CHANGES BY RECOMBINANT ERYTHROPOIETIN THERAPY IN HEMODIALYZED PATIENTS
    SATOH, K
    MASUDA, T
    IKEDA, Y
    KUROKAWA, S
    KAMATA, K
    KIKAWADA, R
    TAKAMOTO, T
    MARUMO, F
    HYPERTENSION, 1990, 15 (03) : 262 - 266
  • [36] SECONDARY TUMORS IN CANCER-PATIENTS AFTER THERAPY
    SVEJDA, J
    LORENZ, I
    NEOPLASMA, 1985, 32 (04) : 495 - 498
  • [37] AN ASSAY FOR MONITORING RESPONSE TO THERAPY IN CANCER-PATIENTS
    WILHIDE, CC
    LARCOM, LL
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1993, 23 (03): : 207 - 215
  • [38] IMIPENEM CILASTATIN THERAPY OF INFECTIONS IN CANCER-PATIENTS
    BODEY, GP
    ELTING, L
    JONES, P
    ALVAREZ, ME
    ROLSTON, K
    FAINSTEIN, V
    CANCER, 1987, 60 (02) : 255 - 262
  • [40] GROUP-THERAPY WITH ADOLESCENT CANCER-PATIENTS
    BAIDER, L
    DENOUR, AK
    JOURNAL OF ADOLESCENT HEALTH, 1989, 10 (01) : 35 - 38